Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$106.89
-0.7%
$113.90
$89.67
$121.64
$185.47B0.745.72 million shs5.05 million shs
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
$2.37
$2.34
$1.27
$13.35
N/AN/AN/AN/A
GRO
Agria Co. American Depo
$0.85
$0.00
$0.71
$1.66
N/AN/A36,354 shsN/A
Itafos Inc. stock logo
IFOS
Itafos
C$1.32
-2.2%
C$1.28
C$1.08
C$2.14
C$252.46M-0.9936,655 shs129,200 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.47%-1.49%-2.71%-2.89%-2.56%
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
0.00%0.00%0.00%0.00%0.00%
GRO
Agria Co. American Depo
0.00%0.00%0.00%0.00%0.00%
Itafos Inc. stock logo
IFOS
Itafos
+2.27%0.00%+7.14%-0.74%-36.62%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9909 of 5 stars
3.35.04.24.52.52.52.5
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/AN/AN/AN/A
GRO
Agria Co. American Depo
N/AN/AN/AN/AN/AN/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5013.67% Upside
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/AN/AN/A
GRO
Agria Co. American Depo
N/AN/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
N/AN/AN/AN/A

Current Analyst Ratings

Latest IFOS, KRPZ, DNK, GRO, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
4/3/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $128.00
2/14/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$128.00
1/26/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$133.00 ➝ $141.00
1/25/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$123.00 ➝ $126.00
1/25/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$128.00
1/25/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$124.00 ➝ $127.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.62$6.35 per share16.83$22.36 per share4.78
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/AN/A
GRO
Agria Co. American Depo
N/AN/AN/AN/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
C$465.52M0.54C$0.17 per share7.77C$1.36 per share0.97

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.3020.882.5813.96%20.32%10.59%7/18/2024 (Estimated)
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/A0.00N/AN/AN/AN/AN/A
GRO
Agria Co. American Depo
N/AN/A0.00N/AN/AN/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
C$3.86MC$0.0344.00N/A0.83%1.21%9.42%N/A

Latest IFOS, KRPZ, DNK, GRO, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.06%+12.31%68.54%53 Years
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/A
GRO
Agria Co. American Depo
N/AN/AN/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
N/AN/AN/AN/AN/A

Latest IFOS, KRPZ, DNK, GRO, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/AN/AN/A
GRO
Agria Co. American Depo
N/AN/AN/A
Itafos Inc. stock logo
IFOS
Itafos
40.13
1.87
0.73

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/A
GRO
Agria Co. American Depo
4.06%
Itafos Inc. stock logo
IFOS
Itafos
0.98%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.47%
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
N/A
GRO
Agria Co. American Depo
N/A
Itafos Inc. stock logo
IFOS
Itafos
67.42%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Phoenix Tree Holdings Limited stock logo
DNK
Phoenix Tree
4,506N/AN/ANot Optionable
GRO
Agria Co. American Depo
N/AN/AN/ANot Optionable
Itafos Inc. stock logo
IFOS
Itafos
417191.26 millionN/ANot Optionable

IFOS, KRPZ, DNK, GRO, and ABT Headlines

SourceHeadline
Investors in Itafos (CVE:IFOS) have seen decent returns of 99% over the past three yearsInvestors in Itafos (CVE:IFOS) have seen decent returns of 99% over the past three years
finance.yahoo.com - April 22 at 3:38 PM
Earth Alive Clean Tech: Top 10 Undervalued Agriculture Industry Stocks (EAC)Earth Alive Clean Tech: Top 10 Undervalued Agriculture Industry Stocks (EAC)
theglobeandmail.com - February 25 at 2:07 PM
Itafos Inc IFOSItafos Inc IFOS
morningstar.com - December 20 at 2:54 PM
Canada Unearthed: The men who made Yamana are back targeting Africa’s golden richesCanada Unearthed: The men who made Yamana are back targeting Africa’s golden riches
msn.com - November 13 at 7:32 AM
Closing Bell: Itafos flat on Tuesday (IFOS)Closing Bell: Itafos flat on Tuesday (IFOS)
theglobeandmail.com - October 19 at 10:40 PM
Itafos (CVE:IFOS) Is Investing Its Capital With Increasing EfficiencyItafos (CVE:IFOS) Is Investing Its Capital With Increasing Efficiency
finance.yahoo.com - September 14 at 10:18 AM
Closing Bell: Itafos up on Thursday (IFOS)Closing Bell: Itafos up on Thursday (IFOS)
theglobeandmail.com - September 8 at 12:14 AM
Itafos Enters Into Monoammonium Phosphate Offtake AgreementItafos Enters Into Monoammonium Phosphate Offtake Agreement
finance.yahoo.com - September 7 at 7:14 PM
Calculating The Intrinsic Value Of Itafos Inc. (CVE:IFOS)Calculating The Intrinsic Value Of Itafos Inc. (CVE:IFOS)
finance.yahoo.com - August 18 at 9:24 AM
Itafos: Top 10 Undervalued Agriculture Industry Stocks (IFOS)Itafos: Top 10 Undervalued Agriculture Industry Stocks (IFOS)
theglobeandmail.com - August 14 at 3:36 PM
Itafos Reports Q2 2023 ResultsItafos Reports Q2 2023 Results
finance.yahoo.com - August 9 at 8:56 PM
Closing Bell: Itafos flat on Friday (IFOS)Closing Bell: Itafos flat on Friday (IFOS)
theglobeandmail.com - August 4 at 7:16 PM
Closing Bell: Itafos down on Friday (IFOS)Closing Bell: Itafos down on Friday (IFOS)
theglobeandmail.com - July 29 at 2:08 AM
IFOS.V - Itafos Inc.IFOS.V - Itafos Inc.
finance.yahoo.com - July 14 at 8:36 PM
Itafos Files Updated Feasibility Study for the Farim Phosphate ProjectItafos Files Updated Feasibility Study for the Farim Phosphate Project
finance.yahoo.com - June 28 at 9:11 AM
Itafos (CVE:IFOS) investors will be pleased with their massive 413% return over the last three yearsItafos' (CVE:IFOS) investors will be pleased with their massive 413% return over the last three years
finance.yahoo.com - June 5 at 9:54 AM
Itafos Completes Updated Feasibility Study for the Farim Phosphate ProjectItafos Completes Updated Feasibility Study for the Farim Phosphate Project
finance.yahoo.com - May 17 at 4:39 PM
Closing Bell: Itafos up on Monday (IFOS)Closing Bell: Itafos up on Monday (IFOS)
theglobeandmail.com - May 16 at 3:45 PM
Itafos Reports Q1 2023 ResultsItafos Reports Q1 2023 Results
finance.yahoo.com - May 10 at 7:20 PM
Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge; Solidifying the Potential for Mineral Resource Life Through 2037(1)Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge; Solidifying the Potential for Mineral Resource Life Through 2037(1)
finance.yahoo.com - May 10 at 2:19 PM
Closing Bell: Itafos down on Tuesday (IFOS)Closing Bell: Itafos down on Tuesday (IFOS)
theglobeandmail.com - May 3 at 3:36 PM
Is Itafos Inc.s (CVE:IFOS) Recent Stock Performance Tethered To Its Strong Fundamentals?Is Itafos Inc.'s (CVE:IFOS) Recent Stock Performance Tethered To Its Strong Fundamentals?
finance.yahoo.com - May 1 at 10:44 AM
Closing Bell: Itafos down on Wednesday (IFOS)Closing Bell: Itafos down on Wednesday (IFOS)
theglobeandmail.com - April 27 at 7:34 PM
Itafos Announces Record of Decision Providing Path to Extend Conda Resource Life Through 2037Itafos Announces Record of Decision Providing Path to Extend Conda Resource Life Through 2037
finance.yahoo.com - April 25 at 11:21 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Phoenix Tree logo

Phoenix Tree

NYSE:DNK
Phoenix Tree Holdings Limited, through its subsidiaries, leases apartments from property owners and rents them to residents and corporate clients in the People's Republic of China. It designs, renovates, and furnishes apartments; and provides WiFi, 24/7 resident support, and common area maintenance and utilities to the residents, as well as repair and maintenance for private rooms. As of December 31, 2019, it operated 438,309 apartment units; and nine apartment facilities under the Dream Apartment brand name with a total of 8,558 beds and four additional facilities in Beijing, Shanghai, and Shenzhen. The company was founded in 2015 and is headquartered in Beijing, China.

Agria Co. American Depo

NYSE:GRO
Agria Corporation is an agricultural company. The Company operates in three business segments: seed and grain; crop protection, nutrients and merchandise, and rural services. The seed and grain segment is engaged in the research and development, production and sale of seed products, including, turf, maize and vegetable seeds. The crop protection, nutrients and merchandise segment operates a chain of retail stores that supply farm input materials, including chemicals, fertilizers, pollination products, frost protection products, fencing, animal health and nutrition products, grains and seeds. The rural services business segment offers services to the agricultural economy, including livestock, wool, irrigation and pumping, real estate and insurance services. It has its business operations and investments in agriculture markets in New Zealand, Australia, South America and China. The Company is also a supplier of crossbred wools.
Itafos logo

Itafos

CVE:IFOS
Itafos Inc. operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil. The company was formerly known as MBAC Fertilizer Corp. and changed its name to Itafos Inc. in December 2016. Itafos Inc. is headquartered in Houston, Texas.